beta 2 Adrenergic Receptor anticorps (pSer355)
Aperçu rapide pour beta 2 Adrenergic Receptor anticorps (pSer355) (ABIN2133124)
Antigène
Voir toutes beta 2 Adrenergic Receptor (ADRB2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer355
-
Immunogène
- ADRB2 antibody was raised in Rabbit using a synthetic phosphopeptide derived from human Adrenergic Receptor B2 around the phosphorylation site of Ser355 and Ser356 (G-Y-SP-SP-N-G) as the immunogen
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- PBS buffer (without Mg2+and Ca2+), pH 7.4, 150 mM NaCl with 0.02 % sodium azide and 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
-
-
-
: "Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101." dans: European journal of pharmacology, Vol. 831, pp. 9-19, (2018) (PubMed).
-
-
- beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
-
Autre désignation
- ADRB2
-
Pathways
- cAMP Metabolic Process, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
Antigène
-